Atopic dermatitis is officially classified as an allergic skin disease, not an autoimmune one, but that clean distinction has been eroding for more than two decades. Research now shows that a majority of people with atopic dermatitis produce antibodies directed against their own skin proteins, and that immune cells extracted from their inflamed skin can attack the body’s own tissues. The condition sits in a gray zone between allergy and autoimmunity, and the more closely scientists look, the blurrier that boundary becomes.
Why the Label Matters
Allergic diseases and autoimmune diseases have traditionally been treated as opposites. In the classic model, allergies involve an overreaction to something from outside the body (pollen, dust mites, pet dander), driven largely by a branch of the immune system that produces IgE antibodies. Autoimmune diseases, by contrast, involve the immune system attacking the body’s own tissues. Different immune pathways were thought to drive each type: one set of helper T cells for allergy, a different set for autoimmunity. That tidy framework guided research and treatment for decades.
The problem is that atopic dermatitis doesn’t stay in its lane. Growing evidence shows that allergy and autoimmunity share overlapping triggers and overlapping immune pathways, with cells traditionally assigned to one camp showing up in the other.1Springer Link. Clinical and Pathophysiological Tangles Between Allergy and Autoimmunity: Deconstructing an Old Dichotomic Paradigm Atopic dermatitis is one of the clearest examples of a condition that straddles the divide.
IgE Antibodies That Target Your Own Skin
The strongest piece of evidence for an autoimmune component in atopic dermatitis comes from IgE autoantibodies. These are antibodies of the same type that react to dust mites or cat dander, except they’re directed against proteins made by the person’s own body. In one study, roughly seven out of ten patients with atopic dermatitis showed IgE reactivity to at least one self-antigen, while none of the healthy controls or psoriasis patients showed any such reactivity.2Journal of Allergy and Clinical Immunology. Repertoire of IgE-binding self-antigens in atopic dermatitis That specificity is striking: the autoimmune reaction wasn’t a general feature of inflamed skin. It was unique to atopic dermatitis.
Across a broader sweep of the research, a systematic review covering over 2,600 participants found that anywhere from about a quarter to nine out of ten atopic dermatitis patients showed IgE autoreactivity, depending on the study. The reaction was consistently absent in healthy people and in those with other inflammatory conditions like psoriasis or lupus. Two of those studies also found a direct link between the degree of autoreactivity and how severe the eczema was.3ScienceDirect (Journal of Allergy and Clinical Immunology). Does “autoreactivity” play a role in atopic dermatitis?
The targets of these autoantibodies are ordinary structural and functional proteins found inside skin cells. Researchers identified several specific self-antigens, including proteins like actin, tubulin, and a protein designated Hom s 1 that was found to be broadly expressed in skin and lung tissue.4PubMed. Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients Other work showed that IgE autoantibodies in atopic dermatitis patients specifically target both cytoplasmic and cell-membrane components of keratinocytes, the main cell type in the outer layer of skin.5PubMed. Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis
Self-Reactive T Cells in Eczema Lesions
Autoantibodies are only half the story. T cells, which are the immune system’s more targeted strike force, also show signs of attacking the body’s own tissue in atopic dermatitis. Researchers have found that T cells directed against skin epitopes appear in adults with severe, chronic atopic dermatitis, and their presence correlates with disease severity.6PubMed. Autoreactive T cells and their role in atopic dermatitis These self-reactive T cells may help explain why the disease keeps flaring even when obvious external triggers like allergens are avoided.
One specific self-antigen, a protein called α-NAC, has been studied in detail. T cells pulled from the inflamed skin of atopic dermatitis patients showed high rates of proliferation when exposed to α-NAC, and the T-cell clones generated from those skin lesions produced inflammatory signaling molecules.7PubMed. The role of T-cell reactivity towards the autoantigen α-NAC in atopic dermatitis In other words, these weren’t passive bystanders. They were actively mounting an immune response against a normal human protein present in the skin.
A Disease That May Shift From Allergic to Autoimmune Over Time
One of the more compelling ideas in this space is that atopic dermatitis might start as a straightforward allergic disease and gradually acquire autoimmune characteristics as it becomes chronic. IgE autoantibodies and self-reactive T cells are most consistently described in patients with severe, long-standing disease, suggesting the immune response escalates over time from targeting external allergens to targeting the body’s own skin.8PubMed Central. IgE autoantibodies and autoreactive T cells and their role in children and adults with atopic dermatitis
This is supported by cytokine data. When researchers compared non-lesional skin, acute flares, and chronic lesions in atopic dermatitis patients, they found that the shift from acute to chronic wasn’t a switch from one immune pathway to another. Instead, all the major inflammatory pathways, including those typically associated with autoimmunity, ramped up together as the disease progressed.9PubMed Central. Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responses The immune system doesn’t pivot; it escalates across the board.
Interestingly, patients with IgE autoantibodies tend to be younger than those without, which complicates a simple “autoimmunity develops later” narrative.10PubMed. Immunoglobulin E autoantibodies in atopic dermatitis associate with Type-2 comorbidities and the atopic march It’s possible that autoimmune features emerge early in some patients and later in others, or that the autoimmune component is part of a broader pattern of immune dysregulation rather than a neat sequential progression.
How a Broken Skin Barrier Exposes the Body to Itself
If your immune system is attacking your own skin proteins, the obvious question is: how did it learn to recognize them as threats in the first place? The answer likely starts with the skin barrier. Atopic dermatitis is strongly associated with defects in the outermost layer of skin, driven by problems like filaggrin deficiency, disrupted lipid organization, altered skin pH, and a disturbed skin microbiome.11PubMed. Epithelial Barrier Dysfunction in Atopic Dermatitis, Allergic Contact Dermatitis, and Chronic Spontaneous Urticaria and its Therapeutic Implications
When that barrier breaks down, proteins that are normally hidden inside intact cells get released into the surrounding tissue and encounter immune cells that wouldn’t normally see them. In a healthy person, these proteins stay behind closed doors. In someone with atopic dermatitis, the immune system encounters them in an inflammatory environment, which is exactly the context in which the body is primed to flag something as dangerous. Once the immune system tags a self-protein as a target, it can keep attacking it even after the original trigger (say, a scratching episode or a flare) resolves.
The “epithelial barrier hypothesis” extends this idea beyond the skin. Researchers have proposed that exposure to barrier-damaging agents linked to modern life, including detergents, surfactants, microplastics, pollutants, and emulsifiers in processed foods, contributes to the rising rates of both allergic and autoimmune diseases by breaking down the epithelial surfaces that normally keep the immune system from encountering certain antigens.12PubMed Central. Epithelial Barrier Theory: The Role of Exposome, Microbiome, and Barrier Function in Allergic Diseases Under this model, the same barrier disruption that lets environmental allergens in could also expose internal proteins to an immune system already on high alert.13PubMed Central. Dysregulation of the epithelial barrier by environmental and other exogenous factors
People With Atopic Dermatitis Are More Likely to Develop Autoimmune Diseases
Beyond the autoimmune-like features of atopic dermatitis itself, there’s a well-documented statistical link between having eczema and developing a recognized autoimmune disease. A systematic review and meta-analysis found that atopic dermatitis was significantly associated with alopecia areata, celiac disease, Crohn’s disease, rheumatoid arthritis, lupus, ulcerative colitis, and vitiligo. The association held up in cohort studies as well, meaning that people who had atopic dermatitis first went on to develop autoimmune diseases at higher rates than those without it.14PubMed Central. Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis
A large population-based study put numbers on the relationship. People with atopic dermatitis had roughly double the odds of having at least one autoimmune disease compared to controls. The connection was strongest for autoimmune conditions affecting the skin, followed by the gastrointestinal tract, and then connective tissue. Patients with multiple autoimmune diseases had an even stronger association with atopic dermatitis than those with just one.15British Journal of Dermatology. Association between atopic dermatitis and autoimmune diseases: a population‐based case–control study
The co-occurrence of atopic dermatitis with conditions like vitiligo and alopecia areata is especially interesting because all three are skin diseases with immune-mediated mechanisms, and some researchers have pointed to shared immune pathways that might explain why they cluster together.16JAMA Dermatology. Association of Vitiligo and Alopecia Areata With Atopic Dermatitis: A Systematic Review and Meta-analysis If atopic dermatitis primes the immune system toward self-reactivity, it would make sense that other autoimmune conditions could develop on that foundation.
Shared Genetics Tell a Complicated Story
Genetics adds another layer. A study examining genetic overlap between atopic dermatitis and autoimmune diseases found 113 independent genomic regions shared between them, with 11 showing a consistent effect across all comparisons. Yet overall genetic correlation between atopic dermatitis and autoimmune diseases was modest, meaning the conditions share specific genetic hotspots without being globally similar at the genome level.17PubMed Central. Shared Genetic Architecture Between Atopic Dermatitis and Autoimmune Diseases
The picture gets more interesting when you look at the direction of effect at those shared genetic loci. In a meta-analysis that identified 29 loci associated with both allergy and autoimmune diseases, about half showed the same direction of effect: the gene variant that increased allergy risk also increased autoimmune risk. But the other half showed the opposite pattern, where the risk allele for allergy was actually protective against the autoimmune disease.18Journal of Allergy and Clinical Immunology. Commonalities in genetic susceptibility loci and genomic regulatory elements between allergy and autoimmune diseases This roughly even split suggests that allergy and autoimmunity aren’t simply different expressions of the same genetic tendency. They share regulatory machinery, but that machinery can push the immune system in either direction depending on context.
Intrinsic Versus Extrinsic Atopic Dermatitis
Not all atopic dermatitis looks the same immunologically. Clinicians distinguish between an “extrinsic” form, which comes with high IgE levels and clear allergic sensitization to environmental triggers, and an “intrinsic” form, where IgE levels are normal and no obvious allergic trigger can be identified. Intrinsic atopic dermatitis accounts for a minority of cases but behaves differently in several ways. Patients with the intrinsic form tend to have a shorter disease course, lower counts of eosinophils and other immune markers, and different demographic patterns compared to those with the extrinsic type.19PubMed. Clinical features and biomarker differences of severe intrinsic and extrinsic atopic dermatitis
The intrinsic form is particularly relevant to the autoimmune question because it lacks the hallmarks of a classic allergic disease. Without elevated IgE against environmental allergens, the ongoing skin inflammation has to be driven by something else. Some researchers have suggested that intrinsic atopic dermatitis may lean more heavily on autoimmune mechanisms, though this remains an active area of investigation. The very existence of an atopic dermatitis subtype that doesn’t fit the allergic mold underscores how inadequate a single-category label is for the disease as a whole.
What Treatments Reveal About the Underlying Biology
Modern treatments for atopic dermatitis have inadvertently shed light on its autoimmune dimension. JAK inhibitors, a class of drugs developed partly for autoimmune conditions like rheumatoid arthritis, have proven effective in atopic dermatitis by blocking the signaling pathways that drive inflammation.20PubMed Central. Targeting the JAK/STAT pathway in atopic dermatitis The fact that drugs designed to calm autoimmune inflammation also work in atopic dermatitis makes it harder to maintain a strict separation between the two categories.
Dupilumab, the biologic most widely used for moderate-to-severe atopic dermatitis, blocks signaling through two key inflammatory molecules. When combined with allergen-specific immunotherapy (which trains the immune system to tolerate external allergens), the combination led to sustained reductions in disease severity along with drops in total IgE and allergen-specific IgE.21PubMed Central. Combined Dupilumab and Allergen-Specific Immunotherapy in Severe Refractory Atopic Dermatitis More detailed immunological data showed that dupilumab reduced IgE levels against specific dust mite components, while immunotherapy boosted protective IgG4 antibodies against those same components. When combined, both effects occurred together.22World Allergy Organization Journal. Allergen immunotherapy and dupilumab in atopic dermatitis: Clinical efficacy and disparities in immunological indicators These results suggest that addressing both the allergic arm (external triggers) and the broader inflammatory arm (which includes self-directed immunity) produces better outcomes than targeting either alone.
The Gut-Skin Connection
Barrier dysfunction in atopic dermatitis isn’t limited to the skin. There’s growing recognition that the gut lining can be disrupted in similar ways, and that the resulting changes in the gut microbiome can influence skin inflammation through immune signaling. The connection between intestinal dysbiosis, increased gut permeability, and inflammatory effects on distant organs like the skin appears to be mediated by the host’s immune system.23PubMed Central. From Leaky Gut to Leaky Skin: A Clinical Review of Lifestyle Influences on the Microbiome This “gut-skin axis” could help explain why atopic dermatitis clusters with autoimmune diseases that affect the gastrointestinal tract, like Crohn’s disease, ulcerative colitis, and celiac disease. If the same types of barrier breakdown and immune activation are happening at both surfaces, the overlap in disease risk starts to make biological sense. The gut-skin axis also reinforces the idea that atopic dermatitis is a systemic inflammatory condition with immune dysregulation at multiple sites, not just a local skin problem driven purely by contact with allergens.
Where the Science Stands on Reclassification
Despite all the evidence for autoimmune features, atopic dermatitis has not been reclassified as an autoimmune disease. The systematic review that assessed autoreactivity across the research made what amounts to the strongest case to date, arguing that the magnitude and specificity of the self-directed immune response, combined with plausible mechanisms and the ability to experimentally provoke eczema by challenging patients with their own proteins, all point toward a causative role for autoreactivity in the disease.24ScienceDirect (Journal of Allergy and Clinical Immunology). Does “autoreactivity” play a role in atopic dermatitis? Still, the field hasn’t arrived at a consensus. Part of the difficulty is that autoimmune features are most pronounced in severe, chronic cases, while mild or early-stage atopic dermatitis often looks more like a straightforward allergic reaction. The disease may not be one thing at all stages in all patients, which makes a single label inadequate. For now, the most honest description might be that atopic dermatitis is an allergic disease with a significant autoimmune component that becomes more prominent as the condition worsens, though individual variation in genetics, barrier function, and environmental exposure means that no two patients sit at exactly the same point on the spectrum.